与神经递质相关的功能连接在阿尔茨海默氏病连续体的变化
Riccardo Manca1,2, Matteo De Marco1, Hilkka Soininen3
1Department of Life Sciences, Brunel University of London, UB8 3PH London, UK.
Brain communications
|February 21, 2025
概括
早期阿尔茨海默氏症涉及多巴胺和乙胆系统的变化. 这些神经递质路径的改变与认知衰退相关,提供潜在的早期诊断标记.
科学领域:
- 神经科学是一个神经科学.
- 神经成像是一种神经成像.
- 痴呆症研究 痴呆症研究
背景情况:
- 阿尔茨海默氏症 (AD) 与早期多巴胺功能障碍有关,但其对神经传递通路的影响尚不清楚.
- 研究神经递质系统对于理解AD的神经功能改变至关重要.
研究的目的:
- 为了检查阿尔茨海默病中多巴胺和胆固醇系统的功能连接性改变.
- 为了将这些连接性变化与不同AD阶段的认知表现相关联.
主要方法:
- 综合的正电子发射断层扫描地图和功能性MRI数据来自86名轻度认知障碍 (MCI) 患者,58名轻度痴呆症患者和76名无障碍患者.
- 使用横截面设计来比较与神经递质相关的跨组功能连接.
- 评估了功能连接和认知表现之间的关联.
主要成果:
- 阿尔茨海默氏病痴呆症组:中皮层临多巴胺连接性下降 (前阴),连接性增加 (脑膜).
- 阿尔茨海默氏病-MCI组:阴侧关节连接性下降 (左侧部区域).
- 两组阿尔茨海默病患者:乙胆连接性下降 (角-角区域). 情节性记忆与特定大脑区域的连接性相关.
结论:
- 多巴胺和乙胆通路的连接性改变与阿尔茨海默病的认知衰退有关.
- 这些神经递质系统的变化可能成为阿尔茨海默病的早期临床标志物.
更多相关视频
相关概念视频
Alzheimer's Disease: Overview
425
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
425
Role of Neurotransmitters in Memory
384
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
384
Alzheimer's Disease: Treatment
149
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
149
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Neurotransmitters
772
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
772
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K


